084650 — Labgenomics Co Balance Sheet
0.000.00%
- KR₩99bn
- KR₩136bn
- KR₩88bn
Annual balance sheet for Labgenomics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 98,898 | 136,871 | 115,391 | 51,364 | 18,519 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 68,495 | 35,552 | 41,154 | 39,966 | 12,394 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 170,931 | 174,483 | 160,378 | 135,567 | 74,479 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 19,698 | 54,885 | 54,957 | 57,359 | 50,266 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 204,287 | 250,653 | 313,457 | 295,662 | 230,149 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 40,683 | 19,896 | 65,055 | 76,315 | 60,162 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 46,571 | 41,322 | 85,662 | 79,348 | 80,527 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 157,715 | 209,331 | 227,795 | 216,314 | 149,622 |
| Total Liabilities & Shareholders' Equity | 204,287 | 250,653 | 313,457 | 295,662 | 230,149 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |